PMC:7402624 / 5705-5963 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"147","span":{"begin":87,"end":94},"obj":"Species"},{"id":"171","span":{"begin":186,"end":193},"obj":"Species"},{"id":"178","span":{"begin":238,"end":240},"obj":"Disease"}],"attributes":[{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"Tax:9606"},{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"Tax:9606"},{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" clinical metadata (Fig. 1A and tables S2 to S4).\nFig. 1 Clinical characterization of patient cohorts, inflammatory markers, and quantification of major immune subsets.\n(A) Overview of patient cohorts in study, including healthy donors (HD), recovered donor"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":238,"end":240},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":" clinical metadata (Fig. 1A and tables S2 to S4).\nFig. 1 Clinical characterization of patient cohorts, inflammatory markers, and quantification of major immune subsets.\n(A) Overview of patient cohorts in study, including healthy donors (HD), recovered donor"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T58","span":{"begin":39,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T59","span":{"begin":39,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T60","span":{"begin":171,"end":172},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" clinical metadata (Fig. 1A and tables S2 to S4).\nFig. 1 Clinical characterization of patient cohorts, inflammatory markers, and quantification of major immune subsets.\n(A) Overview of patient cohorts in study, including healthy donors (HD), recovered donor"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":39,"end":41},"obj":"Chemical"},{"id":"T13","span":{"begin":45,"end":47},"obj":"Chemical"},{"id":"T14","span":{"begin":238,"end":240},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_29401"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"}],"text":" clinical metadata (Fig. 1A and tables S2 to S4).\nFig. 1 Clinical characterization of patient cohorts, inflammatory markers, and quantification of major immune subsets.\n(A) Overview of patient cohorts in study, including healthy donors (HD), recovered donor"}

{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":50,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" clinical metadata (Fig. 1A and tables S2 to S4).\nFig. 1 Clinical characterization of patient cohorts, inflammatory markers, and quantification of major immune subsets.\n(A) Overview of patient cohorts in study, including healthy donors (HD), recovered donor"}